2,2'-azobis(2-amidinopropane) has been researched along with Anemia, Sickle Cell in 2 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tatum, VL | 2 |
Chow, CK | 2 |
Natta, CL | 1 |
2 other studies available for 2,2'-azobis(2-amidinopropane) and Anemia, Sickle Cell
Article | Year |
---|---|
Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress.
Topics: Adult; Amidines; Anemia, Sickle Cell; Antioxidants; Erythrocytes, Abnormal; Female; Hemolysis; Human | 1996 |
Antioxidant status and free radical-induced oxidative damage of sickle erythrocytes.
Topics: Amidines; Anemia, Sickle Cell; Antioxidants; Carotenoids; Erythrocytes; Free Radicals; Glutathione; | 1992 |